First U.S. infants handled in distinctive examine of grownup stem cell remedy for congenital coronary heart illness
In a first-in-children randomized scientific examine, medical researchers on the College of Maryland Faculty of Drugs (UM SOM) and the Interdisciplinary Stem Cell Institute (ISCI) on the College of Miami Miller Faculty of Drugs have begun testing to see whether or not grownup stem cells derived from bone marrow profit youngsters with the congenital coronary heart defect hypoplastic left coronary heart syndrome (HLHS). UM SOM surgeons are injecting the cells into the infants' hearts throughout open-heart operations on the College of Maryland Medical Heart. ISCI is supplying the stem cells for the procedures. Even with intensive surgical remedies, HLHS infants nonetheless don't have optimum outcomes. The researchers hope the cells will enhance the infants' possibilities of survival as HLHS limits the guts's potential to pump blood from the guts to the physique. "The premise of this scientific trial is to spice up or regenerate the precise ventricle, the one...